sports technology labs semaglutide FDA issues warning about some compounded versions of for diabetes, weight loss Getting to the heart of

For years, identifying liver scarring meant undergoing invasive surgical testing

It adjusts cycles based on DOD

After scrapping a Biden-era plan to cover obesity drugs in early 2025, the Trump administration reversed course: it struck deals with Novo Nordisk and Eli Lilly in November 2025 to cut GLP-1 prices, and a voluntary Medicare demonstration begins July 1, 2026 that lets participating drug plans cover GLP-1s for weight loss with a $50 monthly copay

For this reason, these medications are often prescribed for managing type 2 diabetes or obesity

Individuals study BPC-157 to understand its potential role in managing musculoskeletal disorders and healing chronic injuries

Over the years, the FDA has approved three medicines for AUD: disulfiram, acamprosate, and naltrexone, which are only utilized by an estimated 2% of adults with AUD